Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 大理药业股份有限公司（以下简称本公司或公司）原名为大理药业有限公司，始建于1996年，是根据大理市人民政府办公室《大市政办批[1996]68号》批复成立的有限责任公司，由大理制药厂、大理市医药有限公司、云南省弥渡县医药公司共同投资组建，并于1996年10月21日取得大理市工商行政管理局颁发的企业法人营业执照。 2008年1月30日，中华人民共和国商务部出具了商资批[2008]93号《商务部关于同意大理药业有限公司变更为外商投资股份有限公司的批复》，同意大理药业有限变更为股份公司，公司注册资本5,000万元，股本总额为5,000万股。 2008年2月19日，中华人民共和国商务部向公司颁发了商外资资审A[2008]0029号《中华人民共和国台港澳侨投资企业批准证书》。公司本次整体变更为股份公司时发起人的出资已经中和正信会计师事务所有限公司于2008 年3月3日出具的《验资报告》（中和正验字（2008）第5-5号）审验，并于2008年3月19日获得了大理白族自治州工商行政管理局核发的注册号为523900400000116的《企业法人营业执照》。 公司设立时拥有的主要资产为业务经营必需的经营性资产，从事的主要业务为大容量注射剂、小容量注射剂的生产和销售。
Main Business 中药注射剂的生产和销售、医药商业配送业务。
Legal Representative 尹翠仙
Top Executives
董事长：杨君祥
董事长(代)：尹翠仙
副董事长：曾立华,尹翠仙
董事：袁玮,曾继尧,杨君卫,尹翠仙
独立董事：董全亮,李玉兰,姚荣辉
Top 5 Shareholder
Shareholder name Nature Holding Date
杨君祥流通A股23.31%30/09/2024
立兴实业有限公司流通A股18.70%30/09/2024
新疆立兴股权投资管理有限公司流通A股13.50%30/09/2024
杨清龙流通A股11.94%30/09/2024
尹翠仙流通A股3.06%30/09/2024
Company Secretary 吴佩容
Solicitors 上海市通力律师事务所
Auditors 信永中和会计师事务所（特殊普通合伙）
Tel No 0872-8880055
Fax No 0872-8880055
Website www.daliyaoye.cn
Email dongban@daliyaoye.cn
Company Address
Register: 云南省大理市下关环城西路118号
Office: 云南省大理市下关环城西路118号
Listing Date 22/09/2017
Shares Capital
Shares Capital: 219,700,000
Total A Share: 219,700,000
Listed A Share: 219,700,000
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.090
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 1.735
Market Capitalization(RMB) 0.668B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.